GRANULES INDIA
Back to Balance Sheet
|
GRANULES INDIA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹3.04 Cr | ₹3.04 Cr | ₹3.04 Cr | ₹0.99 Cr | ₹0.99 Cr |
What is the latest Contingent Liabilities ratio of GRANULES INDIA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹3.04 Cr |
| Mar2024 | ₹3.04 Cr |
| Mar2023 | ₹3.04 Cr |
| Mar2022 | ₹0.99 Cr |
| Mar2021 | ₹0.99 Cr |
How is Contingent Liabilities of GRANULES INDIA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.04 Cr | 0.00 | |
| Mar2024 | ₹3.04 Cr | 0.00 | |
| Mar2023 | ₹3.04 Cr | 206.14 | |
| Mar2022 | ₹0.99 Cr | 0.00 | |
| Mar2021 | ₹0.99 Cr | - | |
Compare Contingent Liabilities of peers of GRANULES INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GRANULES INDIA | ₹16,680.7 Cr | 3.4% | 14.6% | 44.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -1.4% | -6.2% | -1.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,939.0 Cr | -0.1% | 2.3% | 9.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,109.0 Cr | -1.8% | -4.9% | 28.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,578.0 Cr | -0.4% | -6% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,761.1 Cr | 0.4% | -2.6% | -17.6% | Stock Analytics | |
GRANULES INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GRANULES INDIA | 3.4% |
14.6% |
44.4% |
| SENSEX | 0.5% |
3.2% |
2.3% |
You may also like the below Video Courses